PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Urology, Molinette Hospital-Città della Salute e della Scienza di Torino, University of Turin, Torino, Italy.\', \'Division of Urology, Ospedale San Lazzaro, ASL-CN2 Alba-Bra, Alba, Italy.\', \'Humanitas Gradenigo Hospital, Torino, Italy.\', \'Credit Suisse AG, Zurich, Switzerland.\', \'Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.\', \'Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy.\', \'Rete Oncologica del Piemonte e della Valle d\'Aosta, Torino, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/0391560320946186
?:hasPublicationType
?:journal
  • Urologia
is ?:pmid of
?:pmid
?:pmid
  • 33632087
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.189
?:rankingScore_hIndex
  • 8
is ?:relation_isRelatedTo_publication of
?:title
  • How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d\'Aosta Oncological Network, Italy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all